Home Administrative Billing & Reimbursement BlueCard® Health and Wellness Medical PEAR portal Pharmacy Products Quality Management

​​​​Now in effect: Coverage changes for select injectable asthma drugs

January 4, 2021

​Independence recently changed how we cover specialty drugs Fasenra® (benralizumab) and Nucala® (mepolizumab). When these drugs were first approved by the U.S. Food & Drug Administration (FDA), they required administration by a health care provider and were covered under the medical benefit. In 2019, these drugs became available as self-administered injections. It is now more appropriate for plans to cover Fasenra and Nucala as a pharmacy benefit.

As of January 1, 2021, for members enrolled in commercial plans, Fasenra and Nucala are only covered under the pharmacy benefit.

What does this mean for your Independence patients?

In November, Independence mailed letters to all commercial members who have received these drugs in the past twelve months. The letter explained how this change affects them.

For commercial members who are new to treatment as of January 1, 2021, these drugs are only covered under the member's pharmacy benefit.

Independence Medicare Advantage members are not affected by this change.

We also mailed letters to all providers who have prescribed Fasenra or Nucala in the past twelve months to Independence commercial members. These letters provided detailed information about this change, such as:

  • how members who are currently receiving these drugs are affected;
  • the process for managing existing authorizations and obtaining new authorizations;
  • writing new prescriptions for these drugs so pharmacy benefits managers can fulfill requests.

For providers whose patients require a new prescription and have prescription drug coverage through FutureScripts®*, Optum Specialty Pharmacy® will contact these providers and members to support a successful transition.   

Policy update

Fasenra and Nucala were added to Independence Claim Payment Policy #08.00.78ag: Self-Administered Drugs, which went into effect January 1, 2021.

To view this policy, visit our Medical and Claim Payment Policy Portal.

*FutureScripts is an independent company that provides pharmacy benefits management services.


This content was prepared for the Provider News Center and may not be reproduced in any way without the express written permission of Independence Blue Cross. Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association.
Connect with us     Facebook     Twitter     Flickr     YouTube     Walk the Talk    Independence Pinterest    Independence LinkedIn    Independence Instagram Site Map        Anti-Fraud        Privacy Policy        Legal        Disclaimer
© 2023 Independence Blue Cross.
Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association, serving the health insurance needs of Philadelphia and southeastern Pennsylvania.